Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The primary objective was to evaluate the effect of PCSK9 inhibitors in addition to the background lipid-modifying therapy (LMT), compared with standard LMT in terms of clinical outcomes in patients with coronary CT angiography (CCTA)-detected high-risk plaques.
Epistemonikos ID: 2fd5f1d325611f410f51a734115d972e5596099c
First added on: Mar 22, 2025